DK1334119T3 - Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet - Google Patents
Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitetInfo
- Publication number
- DK1334119T3 DK1334119T3 DK01987765T DK01987765T DK1334119T3 DK 1334119 T3 DK1334119 T3 DK 1334119T3 DK 01987765 T DK01987765 T DK 01987765T DK 01987765 T DK01987765 T DK 01987765T DK 1334119 T3 DK1334119 T3 DK 1334119T3
- Authority
- DK
- Denmark
- Prior art keywords
- motif
- rsv infection
- rsv
- immunity
- compositions
- Prior art date
Links
- 206010061603 Respiratory syncytial virus infection Diseases 0.000 title abstract 4
- 230000036039 immunity Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 102000019034 Chemokines Human genes 0.000 abstract 2
- 108010012236 Chemokines Proteins 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 108010015329 Respiratory syncytial virus G glycoprotein Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24152100P | 2000-10-18 | 2000-10-18 | |
PCT/US2001/032459 WO2002032942A2 (en) | 2000-10-18 | 2001-10-18 | Compositions and methods for modulating rsv infection and immunity |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1334119T3 true DK1334119T3 (da) | 2009-02-23 |
DK1334119T4 DK1334119T4 (da) | 2019-03-18 |
Family
ID=22911027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01987765.3T DK1334119T4 (da) | 2000-10-18 | 2001-10-18 | Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet |
Country Status (9)
Country | Link |
---|---|
US (4) | US20040009177A1 (da) |
EP (1) | EP1334119B2 (da) |
AT (1) | ATE412666T1 (da) |
AU (2) | AU2002224416A1 (da) |
CA (1) | CA2426312C (da) |
DE (1) | DE60136381D1 (da) |
DK (1) | DK1334119T4 (da) |
ES (1) | ES2316487T5 (da) |
WO (1) | WO2002032942A2 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006023029A2 (en) * | 2004-06-16 | 2006-03-02 | The Johns Hopkins University | The cysteine-rich region of respiratory syncytial virus and methods of use therefor |
KR20080113223A (ko) * | 2006-03-06 | 2008-12-29 | 심포젠 에이/에스 | 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체 |
CA2678628A1 (en) * | 2007-03-06 | 2008-09-12 | Symphogen A/S | Recombinant antibodies for treatment of respiratory syncytial virus infections |
CA2703667C (en) | 2007-10-25 | 2015-12-29 | Lawrence M. Kauvar | Anti-rsv g protein antibodies |
GB0724253D0 (en) * | 2007-12-12 | 2008-01-30 | Fermentas Uab | Transfection reagent |
ES2594102T3 (es) * | 2008-04-18 | 2016-12-15 | Vaxinnate Corporation | Mutantes por deleción de la flagelina y métodos para su uso |
US20110318376A1 (en) * | 2008-12-24 | 2011-12-29 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
CA2770304C (en) | 2009-08-04 | 2019-11-26 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, Centers For Disease Control And Prevention | Anti-rsv immunogens and methods of immunization |
US9856456B2 (en) | 2009-10-12 | 2018-01-02 | Thermo Fisher Scientific Baltics Uab | Delivery agent |
GB0917792D0 (en) | 2009-10-12 | 2009-11-25 | Fermentas Uab | Delivery agent |
CN103037898B (zh) | 2010-07-07 | 2016-06-29 | 人工细胞科技公司 | 呼吸道合胞病毒抗原组合物和方法 |
WO2012014780A1 (ja) * | 2010-07-28 | 2012-02-02 | 日産自動車株式会社 | 双極型電極およびそれを用いた双極型二次電池並びに双極型電極の製造方法 |
EP3656396A1 (en) | 2012-08-01 | 2020-05-27 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine |
EP2993009A1 (de) * | 2014-09-08 | 2016-03-09 | HILTI Aktiengesellschaft | Verfahren zur Steuerung eines Wandsägesystems beim Erstellen eines Trennschnittes |
SE539731C2 (sv) | 2016-03-04 | 2017-11-14 | Vertical Wind Ab | Rotor för en elektrisk generator och förfarande för dess tillverkning |
WO2019075400A1 (en) * | 2017-10-13 | 2019-04-18 | Trellis Bioscience, Llc | CONFORMATIONAL EPITOPES IN A CENTRAL PROTECTED REGION OF SYNCYTIAL RESPIRATORY VIRUS PROTEIN G |
US11201095B1 (en) | 2019-08-23 | 2021-12-14 | Xilinx, Inc. | Chip package having a cover with window |
AU2021241450A1 (en) * | 2020-03-23 | 2022-09-15 | Atossa Therapeutics, Inc. | Heparin and N-acetylcysteine for the treatment of a respiratory virus |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2718452B1 (fr) | 1994-04-06 | 1996-06-28 | Pf Medicament | Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation. |
DE69509103T2 (de) | 1994-08-25 | 1999-09-30 | Pepscan Systems Bv | Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv-infektionen |
ATE389018T1 (de) † | 1996-01-24 | 2008-03-15 | Schering Corp | Cx3c chemokin-gene von säugetieren |
AUPO026596A0 (en) | 1996-06-05 | 1996-06-27 | Biomolecular Research Institute Limited | Viral peptide |
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
WO1999001433A1 (fr) | 1997-07-04 | 1999-01-14 | Chisso Corporation | Composes de type cristaux liquides dotes d'une valeur elevee d'anisotropie de permittivite, composition de cristaux liquides contenant ces composes et element d'affichage a cristaux liquides fabrique a partir d'une telle composition de cristaux liquides |
ES2236946T3 (es) | 1997-09-19 | 2005-07-16 | Wyeth Holdings Corporation | Peptidos derivados de la proteina de union (g) del virus respiratorio sincitial. |
FR2827605B1 (fr) | 2001-07-20 | 2004-07-16 | Pf Medicament | Nouveaux peptides derives de la proteine g du vrs et leur utilisation dans un vaccin |
-
2001
- 2001-10-18 EP EP01987765.3A patent/EP1334119B2/en not_active Expired - Lifetime
- 2001-10-18 AU AU2002224416A patent/AU2002224416A1/en not_active Abandoned
- 2001-10-18 CA CA2426312A patent/CA2426312C/en not_active Expired - Lifetime
- 2001-10-18 DE DE60136381T patent/DE60136381D1/de not_active Expired - Lifetime
- 2001-10-18 AT AT01987765T patent/ATE412666T1/de not_active IP Right Cessation
- 2001-10-18 ES ES01987765T patent/ES2316487T5/es not_active Expired - Lifetime
- 2001-10-18 DK DK01987765.3T patent/DK1334119T4/da active
- 2001-10-18 WO PCT/US2001/032459 patent/WO2002032942A2/en active Search and Examination
-
2003
- 2003-04-18 US US10/420,387 patent/US20040009177A1/en not_active Abandoned
-
2005
- 2005-05-26 US US11/139,372 patent/US8173131B2/en not_active Expired - Fee Related
-
2009
- 2009-03-12 AU AU2009200997A patent/AU2009200997B2/en not_active Expired
-
2012
- 2012-01-25 US US13/358,320 patent/US8778354B2/en not_active Expired - Fee Related
-
2014
- 2014-04-15 US US14/252,836 patent/US20140288267A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002224416A1 (en) | 2002-04-29 |
US8173131B2 (en) | 2012-05-08 |
ES2316487T5 (es) | 2019-05-13 |
WO2002032942A3 (en) | 2002-12-12 |
ATE412666T1 (de) | 2008-11-15 |
EP1334119A2 (en) | 2003-08-13 |
EP1334119B1 (en) | 2008-10-29 |
DK1334119T4 (da) | 2019-03-18 |
US20140288267A1 (en) | 2014-09-25 |
US20040009177A1 (en) | 2004-01-15 |
US8778354B2 (en) | 2014-07-15 |
EP1334119B2 (en) | 2018-11-28 |
WO2002032942A2 (en) | 2002-04-25 |
AU2009200997A1 (en) | 2009-04-02 |
CA2426312A1 (en) | 2002-04-25 |
US20120258111A1 (en) | 2012-10-11 |
US20060018925A1 (en) | 2006-01-26 |
AU2009200997B2 (en) | 2011-12-22 |
CA2426312C (en) | 2014-01-14 |
ES2316487T3 (es) | 2009-04-16 |
DE60136381D1 (de) | 2008-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1334119T3 (da) | Sammensætninger og fremgangsmåder til modulering af RSV-infektion og -immunitet | |
ATE327246T1 (de) | Hepatitis c tripeptid inhibitoren | |
MY138860A (en) | Hiv protease inhibitors. | |
DK1644363T3 (da) | Triheterocykliske forbindelser, sammensætninger og fremgangsmåder til behandling af cancer eller virussygdomme | |
IS7533A (is) | Lifrarbólgu C-veirutálmar | |
DE60334205D1 (en) | Heterocyclische sulfonamid-hepatitis-c-virus-hemmer | |
ATE413411T1 (de) | Substituierte cycloalkyl p1' hepatitis c virus inhibitoren | |
ATE475423T1 (de) | Immunostimulierende polynukleotide sequenzen zur verwendung bei der verhinderung und behandlung von viralen erkrankungen | |
DE60024100D1 (de) | Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen | |
DK1479691T3 (da) | Langvarigt aktive fuionspeptidinhibitorer for HIV infektion | |
EA200700976A1 (ru) | Соединения в виде молекул-конъюгатов, обладающих повышенной активностью в отношении включения клеткой | |
MXPA02007271A (es) | Compuestos de tipo pirrol, composiciones que los contienen, y metodos para el tratamiento de cancer o enfermedades virales. | |
DE60137146D1 (de) | Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten | |
IS5956A (is) | Notkun bisfosónsýra til varnar og meðhöndlunar sýkingaferla | |
WO2006109174A3 (en) | Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid | |
DK1778271T3 (da) | Peptid til behandling af herpesvirusinfektioner | |
EP1546415A4 (en) | ANTI-TSG101 ANTIBODIES AND USES THEREOF FOR TREATING VIRAL INFECTIONS | |
DE60236443D1 (de) | Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie | |
WO2003017943A3 (en) | Therapeutic compositions and methods for treating viral infection | |
ATE408421T1 (de) | Pna-konjugat zur therapie von mit hiv in zusammenhang stehenden erkrankungen | |
EP1143981A4 (en) | TREATMENT AND PREVENTION OF HIV AND OTHER VIRUS INFECTIONS | |
ATE237616T1 (de) | Verwendung von (1r,4s)-4-(6-amino-9h-purin-9-yl)- 2-cyclopenten-1-methanol in hbv | |
WO2003008410A8 (en) | Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression | |
DK0470144T3 (da) | D-Asparaginsyre-beta-hydroxamat til behandling af virale infektioner og tumorer | |
ATE212839T1 (de) | Hämoregulatorische verbindungen |